Iris Metals Ltd (ASX: IR1) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Iris Metals Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Iris Metals Ltd (ASX: IR1)
Latest News
Materials Shares
IPO watch: A dig into 2 soon-to-be ASX lithium miners
Share Gainers
3 ASX resources stocks going gangbusters on Wednesday
Materials Shares
Guess which ASX lithium stock is rocketing 44% on a new discovery
Resources Shares
Which ASX lithium shares are performing best in 2022?
Record Highs
3 ASX lithium shares smashing new, all-time highs on Monday
Materials Shares
Back baby! 5 ASX lithium shares smashing all-time highs today
Gold
Guess which ASX gold share has exploded 38% so far this week
IR1 ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|---|---|---|---|---|
YesNo |
About Iris Metals Ltd
Iris Metals Ltd is a minerals exploration company formed for the purposes of applying for and acquiring interests in minerals exploration tenements and tenement applications in Western Australia. It has two projects: the Kookynie and the Leonora Gold project and the Nickel project.
IR1 Share Price History Data provided by Morningstar.
Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
22 Nov 2024 | $0.32 | $0.05 | 18.87% | 430,897 | $0.26 | $0.32 | $0.26 |
21 Nov 2024 | $0.27 | $-0.02 | -7.14% | 56,369 | $0.28 | $0.28 | $0.27 |
20 Nov 2024 | $0.28 | $0.01 | 3.70% | 63,601 | $0.27 | $0.28 | $0.26 |
19 Nov 2024 | $0.27 | $-0.01 | -3.57% | 231,488 | $0.28 | $0.28 | $0.27 |
18 Nov 2024 | $0.28 | $-0.02 | -6.67% | 418,052 | $0.30 | $0.30 | $0.27 |
15 Nov 2024 | $0.30 | $-0.02 | -6.35% | 228,872 | $0.32 | $0.32 | $0.29 |
14 Nov 2024 | $0.32 | $0.05 | 18.52% | 754,821 | $0.31 | $0.33 | $0.29 |
31 Oct 2024 | $0.27 | $0.00 | 0.00% | 86,742 | $0.28 | $0.30 | $0.27 |
30 Oct 2024 | $0.27 | $-0.01 | -3.57% | 124,070 | $0.28 | $0.28 | $0.26 |
29 Oct 2024 | $0.28 | $0.01 | 3.64% | 412,311 | $0.28 | $0.29 | $0.28 |
28 Oct 2024 | $0.28 | $-0.02 | -6.78% | 137,958 | $0.29 | $0.30 | $0.27 |
25 Oct 2024 | $0.30 | $-0.01 | -3.33% | 424,824 | $0.30 | $0.31 | $0.28 |
24 Oct 2024 | $0.30 | $0.00 | 0.00% | 638,110 | $0.30 | $0.32 | $0.28 |
Director Transactions Data provided by Morningstar.
Date | Director | Type | Amount | Value | Notes |
---|---|---|---|---|---|
11 Oct 2024 | Kevin Smith | Buy | 31,500 | $8,313 |
On-market trade.
|
10 Oct 2024 | Kevin Smith | Buy | 17,610 | $2,993 |
On-market trade.
|
13 Sep 2024 | Kevin Smith | Buy | 1,650 | $272 |
On-market trade. https://www.aspecthuntley.com.au/asxdata/20241016/pdf/02867017.pdf
|
13 Sep 2024 | Kevin Smith | Issued | 1,500,000 | $270,000 |
Issue of securities. 1,500,000 Rights
|
29 Aug 2024 | Kevin Smith | Buy | 75,000 | $14,741 |
On-market trade.
|
27 Aug 2024 | Peter Marks | Buy | 105,000 | $20,650 |
On-market trade.
|
14 Aug 2024 | Christopher (Chris) Connell | Expiry | 1,000,000 | $210,000 |
As advised by the company. 4,000,000 rights, LAPSED
|
14 Aug 2024 | Christopher (Chris) Connell | Buy | 1,500,000 | $315,000 |
Exercise of options.
|
14 Aug 2024 | Christopher (Chris) Connell | Exercise | 1,500,000 | $315,000 |
Exercise of options.
|
14 Aug 2024 | Tal Paneth | Sell | 1,000,000 | $200,000 |
On-market trade.
|
01 Jul 2024 | Christopher (Chris) Connell | Buy | 1,500,000 | $540,000 |
Exercise of options.
|
01 Jul 2024 | Christopher (Chris) Connell | Exercise | 1,500,000 | $540,000 |
Exercise of options.
|
14 Feb 2024 | Simon Lill | Issued | 50,000 | $50,000 |
Issue of securities.
|
22 Jan 2024 | Simon Lill | Buy | 50,000 | $32,500 |
On-market trade.
|
19 Jan 2024 | Simon Lill | Buy | 100,000 | $69,150 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Mr Peter Ashley Marks | Executive DirectorExecutive Chairman | Dec 2020 |
Mr Marks has over 35 years' experience in corporate advisory and investment banking. Over the course of his career, he has specialised in capital raisings, IPOs, cross border, M&A transactions, corporate underwriting and venture capital transactions for companies in Australia, the United States and Israel. He has been involved in a range of transactions with a ]focus in the life sciences, biotechnology, medical technology and high tech segments. Peter has served as both an Executive and Non Executive Director of entities which have been listed on the ASX, NASDAQ, and AIM markets. Other current directorships are Alterity Therapeutics Limited (appointed 29 July 2005), Noxopharm Limited (appointed 15 March 2016), EverGreen Lithium Limited (appointed 21 January 2022). Former directorships (last 3 years) include Nyrada Inc (Appointed 16 January 2020, resigned 1 August 2022), Elsight Limited (appointed 9 January 2020, resigned 1 October 2021).
|
Mr Tal Paneth | Non-Executive Director | Feb 2021 |
Mr Paneth has multidisciplinary business experience including exposure to the facets of the equity and debt markets. Tal specialises in identifying strategic mineral projects, financing, and project operations management. Other current directorships is with EverGreen Lithium Limited (appointed 21 January 2022)
|
Mr Kevin Smith | Non-Executive Director | Jun 2024 |
Mr Smith brings IRIS over 20 years of experience in metals trading, marketing and finance. He has helped to build several energy and critical minerals businesses and has knowledge of these supply chains. He was most recently a Managing Director at Traxys,.
|
Mr David James Franks | Company Secretary |
-
|
|
Damien Henderson | Chief Financial Officer and General Manager Operations (Australia) |
-
|
|
David James Franks | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
Mr Tal Paneth | 30,000,000 | 21.58% |
HSBC Custody Nominees (Australia) Limited A/C 2 | 6,022,071 | 4.33% |
HSBC Custody Nominees (Australia) Limited | 5,955,159 | 4.28% |
Jasdak Pty Ltd | 5,500,000 | 3.96% |
NASDAQ Securities Australia Pty Ltd (NASDAQ Securities Aust A/C) | 5,000,000 | 3.60% |
Cody Vincent Schad | 4,000,000 | 2.88% |
Schad Investments LLC | 3,800,000 | 2.73% |
Mr Simon Richard Lill | 3,550,000 | 2.55% |
INVL Group Pty Ltd (Client Holding A/C) | 3,478,500 | 2.50% |
Ledger Holdings Pty Ltd (Mochkin Family No. 2 A/C) | 3,000,000 | 2.16% |
Cameron Richard Pty Ltd (Cameron Richard Super A/C) | 2,329,910 | 1.68% |
Peter Ashley Marks | 2,200,000 | 1.58% |
Mr Ross Frederick Crew | 1,669,515 | 1.20% |
BNP Paribas Nominees Pty Ltd (IB AU Noms Retail Client) | 1,644,926 | 1.18% |
KLI Pty Ltd (The T Teh's Family A/C) | 1,460,000 | 1.05% |
Mr Gregory John Howe & Ms Tracie Lee Vella (Tag Super Fund A/C) | 1,440,000 | 1.04% |
Mr Justin John McNicol (JM Investment A/C) | 1,410,000 | 1.01% |
Mr. Dominic Virgara | 1,246,744 | 0.90% |
Vincent Corp Pty Ltd (The V Barbagallo Family A/C) | 1,024,794 | 0.74% |
John W King Nominees Pty Ltd | 1,000,000 | 0.72% |